ALX ONCOLOGY HOLDINGS INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $363.0M | $363.7M |
| FY2022 | $9.4M | $263.5M | $48.8M |
| FY2023 | $9.6M | $189.7M | $22.4M |
| FY2024 | $9.5M | $113.6M | $17.6M |
| FY2025 | $4.5M | $26.0M | $16.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $363.0M | $363.7M |
| FY2022 | $9.4M | $263.5M | $48.8M |
| FY2023 | $9.6M | $189.7M | $22.4M |
| FY2024 | $9.5M | $113.6M | $17.6M |
| FY2025 | $4.5M | $26.0M | $16.4M |